AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 24-E-02-005.01
CMS should educate enrollees and providers about options for access to overdose-reversal medications, as Narcan and its generic equivalents will no…
The recommendation, in the publisher's words
CMS should educate enrollees and providers about options for access to overdose-reversal medications, as Narcan and its generic equivalents will no longer be covered by Part D.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- December 11, 2023
- Report
- The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern (OEI-02-23-00250) · find it at HHS OIG
- Kind of report
- Evaluation
- Agency response
- Concur (as recorded by the publisher)
- Last update received
- September 16, 2026
- Next update expected
- October 5, 2027 (publisher's date)
- Publisher topics
- Managed Care, Mental Health, Prescription Drug, Public Health Issues, Quality of Care, Substance Abuse Disorder
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.